Cargando…
Sprinkle formulations—A review of commercially available products
Currently, sixty-five original sprinkle drug products are available in various dosage forms including tablets, powders, granules, immediate-release capsules, extended-release capsules, delayed-release capsules, and multiparticulate drug delivery systems. By sprinkling on soft food vehicles, these pr...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shenyang Pharmaceutical University
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327757/ https://www.ncbi.nlm.nih.gov/pubmed/32636948 http://dx.doi.org/10.1016/j.ajps.2019.05.003 |
_version_ | 1783552608449855488 |
---|---|
author | Lee, Han Sol Lee, Jeong-Jun Kim, Myeong-Gyu Kim, Ki-Taek Cho, Cheong-Weon Kim, Dae-Duk Lee, Jae-Young |
author_facet | Lee, Han Sol Lee, Jeong-Jun Kim, Myeong-Gyu Kim, Ki-Taek Cho, Cheong-Weon Kim, Dae-Duk Lee, Jae-Young |
author_sort | Lee, Han Sol |
collection | PubMed |
description | Currently, sixty-five original sprinkle drug products are available in various dosage forms including tablets, powders, granules, immediate-release capsules, extended-release capsules, delayed-release capsules, and multiparticulate drug delivery systems. By sprinkling on soft food vehicles, these products provide dosing flexibility and convenience of administration, which potentially improve the compliance of patients with dysphagia. Due to these advantages, the growth of sprinkle products picked up since the 1990s, and several regulatory issues regarding this dosage form have been raised and documented. In this article, the types of sprinkle formulations were discussed by dividing them into seven categories, and the commercial products were summarized in terms of the drug substance, pharmaceutical excipients, storage conditions and administration methods. In addition, several US Food and Drug Administration guidelines related to the regulatory issues of sprinkle formulations were reviewed, which led to the conclusion that the future development of this promising dosage form demands integrated guidance for industry rather than scattered information in various documents. |
format | Online Article Text |
id | pubmed-7327757 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Shenyang Pharmaceutical University |
record_format | MEDLINE/PubMed |
spelling | pubmed-73277572020-07-06 Sprinkle formulations—A review of commercially available products Lee, Han Sol Lee, Jeong-Jun Kim, Myeong-Gyu Kim, Ki-Taek Cho, Cheong-Weon Kim, Dae-Duk Lee, Jae-Young Asian J Pharm Sci Review article Currently, sixty-five original sprinkle drug products are available in various dosage forms including tablets, powders, granules, immediate-release capsules, extended-release capsules, delayed-release capsules, and multiparticulate drug delivery systems. By sprinkling on soft food vehicles, these products provide dosing flexibility and convenience of administration, which potentially improve the compliance of patients with dysphagia. Due to these advantages, the growth of sprinkle products picked up since the 1990s, and several regulatory issues regarding this dosage form have been raised and documented. In this article, the types of sprinkle formulations were discussed by dividing them into seven categories, and the commercial products were summarized in terms of the drug substance, pharmaceutical excipients, storage conditions and administration methods. In addition, several US Food and Drug Administration guidelines related to the regulatory issues of sprinkle formulations were reviewed, which led to the conclusion that the future development of this promising dosage form demands integrated guidance for industry rather than scattered information in various documents. Shenyang Pharmaceutical University 2020-05 2019-07-08 /pmc/articles/PMC7327757/ /pubmed/32636948 http://dx.doi.org/10.1016/j.ajps.2019.05.003 Text en © 2019 Shenyang Pharmaceutical University. Published by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review article Lee, Han Sol Lee, Jeong-Jun Kim, Myeong-Gyu Kim, Ki-Taek Cho, Cheong-Weon Kim, Dae-Duk Lee, Jae-Young Sprinkle formulations—A review of commercially available products |
title | Sprinkle formulations—A review of commercially available products |
title_full | Sprinkle formulations—A review of commercially available products |
title_fullStr | Sprinkle formulations—A review of commercially available products |
title_full_unstemmed | Sprinkle formulations—A review of commercially available products |
title_short | Sprinkle formulations—A review of commercially available products |
title_sort | sprinkle formulations—a review of commercially available products |
topic | Review article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327757/ https://www.ncbi.nlm.nih.gov/pubmed/32636948 http://dx.doi.org/10.1016/j.ajps.2019.05.003 |
work_keys_str_mv | AT leehansol sprinkleformulationsareviewofcommerciallyavailableproducts AT leejeongjun sprinkleformulationsareviewofcommerciallyavailableproducts AT kimmyeonggyu sprinkleformulationsareviewofcommerciallyavailableproducts AT kimkitaek sprinkleformulationsareviewofcommerciallyavailableproducts AT chocheongweon sprinkleformulationsareviewofcommerciallyavailableproducts AT kimdaeduk sprinkleformulationsareviewofcommerciallyavailableproducts AT leejaeyoung sprinkleformulationsareviewofcommerciallyavailableproducts |